United Therapeutics Corporation Investment Income, Interest
United Therapeutics Corporation (UTHR) reported Investment Income, Interest of $31.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-05
- United Therapeutics Corporation investment income, interest for the quarter ending 2026-06-30 was $31.50M, a 38.60% decline year-over-year.
- United Therapeutics Corporation investment income, interest for the quarter ending 2026-03-31 was $41.80M, a 18.20% decline year-over-year.
- United Therapeutics Corporation investment income, interest for the quarter ending 2025-12-31 was $43.20M, a 12.37% decline year-over-year.
- United Therapeutics Corporation investment income, interest for the quarter ending 2025-09-30 was $46.40M, a 6.83% decline year-over-year.
- United Therapeutics Corporation investment income, interest for fiscal 2025 was $192.00M, a 3.57% decline from fiscal 2024.
- United Therapeutics Corporation investment income, interest for fiscal 2024 was $199.10M, a 22.37% increase from fiscal 2023.
- United Therapeutics Corporation investment income, interest for fiscal 2023 was $162.70M, a 259.96% increase from fiscal 2022.
- United Therapeutics Corporation investment income, interest for fiscal 2022 was $45.20M, a 170.66% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $31.50M 10-Q · filed 2026-08-05 | $73.30M 10-Q · filed 2026-08-05 | $116.50M derived: sum of 3 quarters · filed 2026-08-05 | $162.90M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $41.80M 10-Q · filed 2026-05-06 | $85.00M derived: sum of 2 quarters · filed 2026-05-06 | $131.40M derived: sum of 3 quarters · filed 2026-05-06 | $182.70M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $43.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $89.60M derived: sum of 2 quarters · filed 2026-02-25 | $140.90M derived: sum of 3 quarters · filed 2026-08-05 | $192.00M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $46.40M 10-Q · filed 2025-10-29 | $97.70M derived: sum of 2 quarters · filed 2026-08-05 | $148.80M 10-Q · filed 2025-10-29 | $198.10M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $51.30M 10-Q · filed 2026-08-05 | $102.40M 10-Q · filed 2026-08-05 | $151.70M derived: sum of 3 quarters · filed 2026-08-05 | $201.50M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $51.10M 10-Q · filed 2026-05-06 | $100.40M derived: sum of 2 quarters · filed 2026-05-06 | $150.20M derived: sum of 3 quarters · filed 2026-05-06 | $196.40M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $49.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $99.10M derived: sum of 2 quarters · filed 2026-02-25 | $145.30M derived: sum of 3 quarters · filed 2026-02-25 | $199.10M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $49.80M 10-Q · filed 2025-10-29 | $96.00M derived: sum of 2 quarters · filed 2025-10-29 | $149.80M 10-Q · filed 2025-10-29 | $200.80M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $46.20M 10-Q · filed 2025-07-30 | $100.00M 10-Q · filed 2025-07-30 | $151.00M derived: sum of 3 quarters · filed 2026-02-25 | $196.30M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $53.80M 10-Q · filed 2025-04-30 | $104.80M derived: sum of 2 quarters · filed 2026-02-25 | $150.10M derived: sum of 3 quarters · filed 2026-02-25 | $187.30M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $96.30M derived: sum of 2 quarters · filed 2026-02-25 | $133.50M derived: sum of 3 quarters · filed 2026-02-25 | $162.70M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $45.30M 10-Q · filed 2024-10-30 | $82.50M derived: sum of 2 quarters · filed 2024-10-30 | $111.70M 10-Q · filed 2024-10-30 | $132.50M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $37.20M 10-Q · filed 2024-07-31 | $66.40M 10-Q · filed 2024-07-31 | $87.20M derived: sum of 3 quarters · filed 2025-02-26 | $100.50M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $29.20M 10-Q · filed 2024-05-01 | $50.00M derived: sum of 2 quarters · filed 2025-02-26 | $63.30M derived: sum of 3 quarters · filed 2025-02-26 | $70.10M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $34.10M derived: sum of 2 quarters · filed 2025-02-26 | $40.90M derived: sum of 3 quarters · filed 2025-02-26 | $45.20M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $13.30M 10-Q · filed 2023-11-01 | $20.10M derived: sum of 2 quarters · filed 2023-11-01 | $24.40M 10-Q · filed 2023-11-01 | $28.60M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $6.80M 10-Q · filed 2023-08-02 | $11.10M 10-Q · filed 2023-08-02 | $15.30M derived: sum of 3 quarters · filed 2024-02-21 | $19.10M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $4.30M 10-Q · filed 2023-05-03 | $8.50M derived: sum of 2 quarters · filed 2024-02-21 | $12.30M derived: sum of 3 quarters · filed 2024-02-21 | $16.30M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $8.00M derived: sum of 2 quarters · filed 2024-02-21 | $12.00M derived: sum of 3 quarters · filed 2024-02-21 | $16.70M 10-K · filed 2024-02-21 | |
| 2021-09-30 | $3.80M 10-Q · filed 2022-11-02 | $7.80M derived: sum of 2 quarters · filed 2022-11-02 | $12.50M 10-Q · filed 2022-11-02 | $17.50M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | $4.00M 10-Q · filed 2022-08-03 | $8.70M 10-Q · filed 2022-08-03 | $13.70M derived: sum of 3 quarters · filed 2023-02-22 | $20.10M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | $4.70M 10-Q · filed 2022-05-04 | $9.70M derived: sum of 2 quarters · filed 2023-02-22 | $16.10M derived: sum of 3 quarters · filed 2023-02-22 | $23.30M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $11.40M derived: sum of 2 quarters · filed 2023-02-22 | $18.60M derived: sum of 3 quarters · filed 2023-02-22 | $28.60M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $6.40M 10-Q · filed 2021-11-03 | $13.60M derived: sum of 2 quarters · filed 2021-11-03 | $23.60M 10-Q · filed 2021-11-03 | $35.10M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $7.20M 10-Q · filed 2021-08-04 | $17.20M 10-Q · filed 2021-08-04 | $28.70M derived: sum of 3 quarters · filed 2022-02-24 | $40.80M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $10.00M 10-Q · filed 2021-05-05 | $21.50M derived: sum of 2 quarters · filed 2022-02-24 | $33.60M derived: sum of 3 quarters · filed 2022-02-24 | $44.40M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $23.60M derived: sum of 2 quarters · filed 2022-02-24 | $34.40M derived: sum of 3 quarters · filed 2022-02-24 | $44.20M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $12.10M 10-Q · filed 2020-10-28 | $22.90M derived: sum of 2 quarters · filed 2020-10-28 | $32.70M 10-Q · filed 2020-10-28 | $41.40M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $10.80M 10-Q · filed 2020-07-29 | $20.60M 10-Q · filed 2020-07-29 | $29.30M derived: sum of 3 quarters · filed 2021-02-24 | $37.20M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $9.80M 10-Q · filed 2020-04-29 | $18.50M derived: sum of 2 quarters · filed 2021-02-24 | $26.40M derived: sum of 3 quarters · filed 2021-02-24 | $33.10M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $16.60M derived: sum of 2 quarters · filed 2021-02-24 | $23.30M derived: sum of 3 quarters · filed 2021-02-24 | $28.60M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $7.90M 10-Q · filed 2019-10-30 | $14.60M derived: sum of 2 quarters · filed 2019-10-30 | $19.90M 10-Q · filed 2019-10-30 | $25.10M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | $6.70M 10-Q · filed 2019-07-31 | $12.00M 10-Q · filed 2019-07-31 | $17.20M derived: sum of 3 quarters · filed 2020-02-26 | $19.40M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-03-31 | $5.30M 10-Q · filed 2019-05-01 | $10.50M derived: sum of 2 quarters · filed 2020-02-26 | $12.70M derived: sum of 3 quarters · filed 2020-02-26 | ||
| 2017-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $7.40M derived: sum of 2 quarters · filed 2020-02-26 | $10.90M 10-K · filed 2020-02-26 | ||
| 2017-09-30 | $2.20M 10-Q · filed 2018-10-31 | $5.70M 10-Q · filed 2018-10-31 | |||
| 2016-12-31 | $3.50M 10-K · filed 2019-02-27 | ||||
| 2014-06-30 | $1.11M 10-Q · filed 2014-07-29 | $2.34M 10-Q · filed 2014-07-29 | $3.45M derived: sum of 3 quarters · filed 2014-07-29 | $4.32M derived: sum of 4 quarters · filed 2014-07-29 | |
| 2014-03-31 | $1.23M 10-Q · filed 2014-04-29 | $2.34M derived: sum of 2 quarters · filed 2014-04-29 | $3.21M derived: sum of 3 quarters · filed 2014-04-29 | $4.08M derived: sum of 4 quarters · filed 2014-07-29 | |
| 2013-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.98M derived: sum of 2 quarters · filed 2014-02-25 | $2.85M derived: sum of 3 quarters · filed 2014-07-29 | $3.83M 10-K · filed 2014-02-25 | |
| 2013-09-30 | $868.00K 10-Q · filed 2013-10-29 | $1.74M derived: sum of 2 quarters · filed 2014-07-29 | $2.72M 10-Q · filed 2013-10-29 | $3.43M derived: sum of 4 quarters · filed 2014-07-29 | |
| 2013-06-30 | $869.00K 10-Q · filed 2014-07-29 | $1.85M 10-Q · filed 2014-07-29 | $2.56M derived: sum of 3 quarters · filed 2014-07-29 | $3.70M derived: sum of 4 quarters · filed 2014-07-29 | |
| 2013-03-31 | $979.00K 10-Q · filed 2014-04-29 | $1.70M derived: sum of 2 quarters · filed 2014-04-29 | $2.83M derived: sum of 3 quarters · filed 2014-04-29 | $3.89M derived: sum of 4 quarters · filed 2014-04-29 | |
| 2012-12-31 | $716.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.85M derived: sum of 2 quarters · filed 2014-02-25 | $2.91M derived: sum of 3 quarters · filed 2014-02-25 | $3.94M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $1.14M 10-Q · filed 2013-10-29 | $2.19M derived: sum of 2 quarters · filed 2013-10-29 | $3.23M 10-Q · filed 2013-10-29 | $4.16M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-06-30 | $1.05M 10-Q · filed 2013-07-25 | $2.09M 10-Q · filed 2013-07-25 | $3.02M derived: sum of 3 quarters · filed 2014-02-25 | $4.03M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-03-31 | $1.03M 10-Q · filed 2013-04-25 | $1.96M derived: sum of 2 quarters · filed 2014-02-25 | $2.98M derived: sum of 3 quarters · filed 2014-02-25 | $3.82M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2011-12-31 | $930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.95M derived: sum of 2 quarters · filed 2014-02-25 | $2.79M derived: sum of 3 quarters · filed 2014-02-25 | $3.45M 10-K · filed 2014-02-25 | |
| 2011-09-30 | $1.02M 10-Q · filed 2012-11-01 | $1.85M derived: sum of 2 quarters · filed 2012-11-01 | $2.52M 10-Q · filed 2012-11-01 | $3.15M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-06-30 | $839.00K 10-Q · filed 2012-07-26 | $1.50M 10-Q · filed 2012-07-26 | $2.14M derived: sum of 3 quarters · filed 2013-02-26 | $2.70M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-03-31 | $666.00K 10-Q · filed 2012-04-26 | $1.30M derived: sum of 2 quarters · filed 2013-02-26 | $1.86M derived: sum of 3 quarters · filed 2013-02-26 | $2.66M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2010-12-31 | $631.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $1.20M derived: sum of 2 quarters · filed 2013-02-26 | $2.00M derived: sum of 3 quarters · filed 2013-02-26 | $2.94M 10-K · filed 2013-02-26 | |
| 2010-09-30 | $564.00K 10-Q · filed 2011-10-27 | $1.37M derived: sum of 2 quarters · filed 2011-10-27 | $2.31M 10-Q · filed 2011-10-27 | $2.31M 10-Q · filed 2010-10-28 | $3.31M derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-06-30 | $802.00K 10-Q · filed 2011-07-28 | $1.75M 10-Q · filed 2011-07-28 | $2.75M derived: sum of 3 quarters · filed 2012-02-28 | $3.84M derived: sum of 4 quarters · filed 2012-02-28 | |
| 2010-03-31 | $944.00K 10-Q · filed 2011-04-28 | $1.95M derived: sum of 2 quarters · filed 2012-02-28 | $3.03M derived: sum of 3 quarters · filed 2012-02-28 | $4.37M derived: sum of 4 quarters · filed 2012-02-28 | |
| 2009-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $2.09M derived: sum of 2 quarters · filed 2012-02-28 | $3.42M derived: sum of 3 quarters · filed 2012-02-28 | $5.15M 10-K · filed 2012-02-28 | |
| 2009-09-30 | $1.08M 10-Q · filed 2010-10-28 | $2.42M derived: sum of 2 quarters · filed 2010-10-28 | $4.14M 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | $1.33M 10-Q · filed 2010-07-28 | $3.06M 10-Q · filed 2010-07-28 | |||
| 2008-12-31 | $11.03M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |